Product Benefits (Focusing on Medical Efficacy)

• Dual-Action Control: Provides long-term, twice-daily maintenance treatment for chronic respiratory conditions by combining an anti-inflammatory corticosteroid (Budesonide) with a long-acting bronchodilator (Formoterol).

• Effective for Asthma: Indicated for the maintenance treatment of asthma in patients (typically 12 years and older) who are not adequately controlled on an Inhaled Corticosteroid alone.

• COPD Maintenance: Used for the twice-daily maintenance treatment of airflow obstruction in Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema.

• Reduces Inflammation and Opens Airways: Budesonide reduces inflammation in the airways, while Formoterol quickly relaxes the muscles in the lungs, improving breathing and reducing the frequency of exacerbations.

• Rapid Onset of Action: Formoterol provides a bronchodilating effect with a rapid onset (within 1-3 minutes) and a long duration (at least 12 hours)